| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176639 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050175724 Composition for modulating at least one physiological reaction or inducing an immune response in human or animal after oral administration; for intestinal delivery of a physiologically active agent, a neutralizing agent, an inhibitor of digestive enzymes, an uptake increasing agent; synergistic |
| 08/11/2005 | US20050175636 Containing stabilized neurotoxin as analgesic and skin penetration enhancing agent; inflammation and/or pain reduction |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1324760A4 Creatine ester pronutrient compounds and formulations |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653036A Amino acids with affinity for the alpha-2-delta-protein |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/10/2005 | CN1652802A Methods of treating necrotizing enterocolitis |
| 08/10/2005 | CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/10/2005 | CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1214114C Activatable recombinant neurotoxins |
| 08/10/2005 | CN1214043C Humanized antibodies to gamma-interferon |
| 08/10/2005 | CN1214022C Vitamin D analogues |
| 08/10/2005 | CN1214017C 四唑衍生物 Tetrazole derivatives |
| 08/10/2005 | CN1213733C Method of preparing stable suspension of insoluble microparticles |
| 08/09/2005 | US6927317 Modulating ramp activity |
| 08/09/2005 | US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 08/09/2005 | US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 08/09/2005 | US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 08/09/2005 | US6927231 and stress-related degenerative processes associated with aging or diseases such as cancer, neurodegenerative disease or dysregulation of redox-regulated physiological processes, indicated by prooxidative shift in plasma thiol/disulfide redox state |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents |
| 08/09/2005 | US6927218 Aryl N-cyanoguanidines and methods related thereto |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/09/2005 | CA2258892C Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als) |
| 08/04/2005 | WO2005071071A1 Ptd-human choline acetyltransferase fusion protein and its application |
| 08/04/2005 | WO2004007457A3 Substituted benzylamine derivatives and methods of use |
| 08/04/2005 | US20050171206 sodium, potassium, magnesium, calcium and arginine salts of phenylbutyrate; treatment of spinal muscular atrophy; an autosomal recessive condition |
| 08/04/2005 | US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/04/2005 | US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 08/04/2005 | US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders |
| 08/04/2005 | US20050171135 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-Y1]-spiro[isobenzofuran-1(3H), 4'-piperidine]hydrohalogenides |
| 08/04/2005 | US20050171118 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 08/04/2005 | US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone |
| 08/04/2005 | US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171084 Methods of treatment with lxr modulators |
| 08/04/2005 | US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity |
| 08/04/2005 | US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II |
| 08/04/2005 | US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma |
| 08/04/2005 | US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/04/2005 | US20050169967 Surgical material comprising water glass fibres |
| 08/03/2005 | EP1429750A4 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 08/03/2005 | EP1142890B1 Aminopyrazole derivatives |
| 08/03/2005 | EP0998288B2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives |
| 08/03/2005 | CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 08/03/2005 | CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649853A Thiazolidinones compound, its preparing method and use as medicine |
| 08/03/2005 | CN1649849A Tachykinin receptor antagonists |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649826A 5-amino-1-pentene-3-ol substituted derivatives |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1648135A Transduction peptide-humanized chloine acetylase fusion protein and its use |
| 08/03/2005 | CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors |
| 08/03/2005 | CN1212831C Pharmaceutical preparations |
| 08/02/2005 | US6924374 Modulators of dopamine neurotransmission |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
| 07/28/2005 | WO2005026337A3 Adenoviral vector for infecting cells deficient in a car receptor |
| 07/28/2005 | US20050165256 Aminating compounds such as 3,5-dichloroaniline in the presence of ammonia and a catalyst selected from the group consisting of copper salts, cupric and cuprous oxides and mixtures, heating and pressurization |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165030 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/28/2005 | US20050165023 Imidazo-triazine derivatives as ligands for gaba receptors |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164342 Cloned glutamic acid decarboxylase |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163839 Oral controlled release pharmaceutical composition containing metaxalone as active agent |
| 07/28/2005 | US20050163809 Remedy for hypermyotonia |
| 07/28/2005 | US20050163719 Buccal, polar and non-polar spray containing diazepam |
| 07/27/2005 | EP1557427A2 Hedgehog protein conjugate |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1148873B1 Highly purified ethyl epa and other epa derivatives for neurological disorders |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646500A Aryl substituted pyrimidines and the use thereof |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |